Found: 6
Select item for more details and to access through your institution.
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10043-0
- By:
- Publication type:
- Article
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51014-1
- By:
- Publication type:
- Article
ATRT-03. EFFICACY OF THE ONCOLYTIC ADENOVIRUS DELTA-24-RGD AS A THERAPEUTIC AGENT FOR THE TREATMENT OF PEDIATRIC EMBRYONAL BRAIN TUMORS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii63, doi. 10.1093/neuonc/noz036.002
- By:
- Publication type:
- Article
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [<sup>18</sup>F]FDG and sodium [<sup>18</sup>F]fluoride PET.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 8, p. 1509, doi. 10.1093/neuonc/noae066
- By:
- Publication type:
- Article
The Oncolytic Adenovirus Δ24-RGD in Combination With Cisplatin Exerts a Potent Anti-Osteosarcoma Activity.
- Published in:
- Journal of Bone & Mineral Research, 2014, v. 29, n. 10, p. 2287, doi. 10.1002/jbmr.2253
- By:
- Publication type:
- Article